                         SEQUENCE LISTING

<110>  TEXAS TECH UNIVERSITY SYSTEM
 
<120>  AD36E4ORF1: A POSSIBLE THERAPEUTIC TREATMENT FOR ALZHEIMER'S 
       DISEASE

<130>  13368-P020WO

<150>  US 62/884,150
<151>  2019-08-07

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  378
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Ad-36 E4 orf 1 DNA Sequence

<400>  1
atggctgaat ctctgtatgc tttcatagat agccctggag ggatcgctcc cgtccaggaa       60

ggggctagca atagatatat cttcttttgc cccgaatctt tccacattcc tccgcatggg      120

gtgatattgc ttcacctcag agtgagcgtg ctggttccta ctggatatca gggcagattt      180

atggccttga atgactacca tgccaggggc atactaaccc agtccgatgt gatatttgcc      240

gggagaagac atgatctctc tgtgctgctc tttaaccaca cggaccgatt tttgtatgtc      300

cgcgagggcc acccagtggg aaccctgctg ctggagagag tgatttttcc ttcagtgaga      360

atagccaccc tggtttag                                                    378


<210>  2
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Ad-36 E4 orf 1 Protein Translation

<400>  2

Met Ala Glu Ser Leu Tyr Ala Phe Ile Asp Ser Pro Gly Gly Ile Ala 
1               5                   10                  15      


Pro Val Gln Glu Gly Ala Ser Asn Arg Tyr Ile Phe Phe Cys Pro Glu 
            20                  25                  30          


Ser Phe His Ile Pro Pro His Gly Val Ile Leu Leu His Leu Arg Val 
        35                  40                  45              


Ser Val Leu Val Pro Thr Gly Tyr Gln Gly Arg Phe Met Ala Leu Asn 
    50                  55                  60                  


Asp Tyr His Ala Arg Gly Ile Leu Thr Gln Ser Asp Val Ile Phe Ala 
65                  70                  75                  80  


Gly Arg Arg His Asp Leu Ser Val Leu Leu Phe Asn His Thr Asp Arg 
                85                  90                  95      


Phe Leu Tyr Val Arg Glu Gly His Pro Val Gly Thr Leu Leu Leu Glu 
            100                 105                 110         


Arg Val Ile Phe Pro Ser Val Arg Ile Ala Thr Leu Val 
        115                 120                 125 


<210>  3
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Ad-36 E4 orf 1 (delta)PDZ DNA Sequence

<400>  3
atggctgaat ctctgtatgc tttcatagat agccctggag ggatcgctcc cgtccaggaa       60

ggggctagca atagatatat cttcttttgc cccgaatctt tccacattcc tccgcatggg      120

gtgatattgc ttcacctcag agtgagcgtg ctggttccta ctggatatca gggcagattt      180

atggccttga atgactacca tgccaggggc atactaaccc agtccgatgt gatatttgcc      240

gggagaagac atgatctctc tgtgctgctc tttaaccaca cggaccgatt tttgtatgtc      300

cgcgagggcc acccagtggg aaccctgctg ctggagagag tgatttttcc ttcagtgaga      360

atatag                                                                 366


<210>  4
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Ad-36 E4 orf 1 (delta)PDZ Protein Translation

<400>  4

Met Ala Glu Ser Leu Tyr Ala Phe Ile Asp Ser Pro Gly Gly Ile Ala 
1               5                   10                  15      


Pro Val Gln Glu Gly Ala Ser Asn Arg Tyr Ile Phe Phe Cys Pro Glu 
            20                  25                  30          


Ser Phe His Ile Pro Pro His Gly Val Ile Leu Leu His Leu Arg Val 
        35                  40                  45              


Ser Val Leu Val Pro Thr Gly Tyr Gln Gly Arg Phe Met Ala Leu Asn 
    50                  55                  60                  


Asp Tyr His Ala Arg Gly Ile Leu Thr Gln Ser Asp Val Ile Phe Ala 
65                  70                  75                  80  


Gly Arg Arg His Asp Leu Ser Val Leu Leu Phe Asn His Thr Asp Arg 
                85                  90                  95      


Phe Leu Tyr Val Arg Glu Gly His Pro Val Gly Thr Leu Leu Leu Glu 
            100                 105                 110         


Arg Val Ile Phe Pro Ser Val Arg Ile 
        115                 120     


